Understanding the Hematological Cancer Research Investment and Education Act

Definition & Meaning

The Hematological Cancer Research Investment and Education Act is a law established in 2001 to promote research and education focused on blood cancers. This Act modifies the Public Health Service Act to enhance the coordination and funding of blood cancer research programs. It also mandates the creation of educational initiatives aimed at informing patients and the public about these diseases.

Table of content

Real-world examples

Here are a couple of examples of abatement:

One example of the Act's impact is the funding of clinical trials for new treatments for leukemia, which allows researchers to explore innovative therapies. Another example is the development of educational materials that help patients understand their diagnosis and treatment options (hypothetical example).

Comparison with related terms

Term Definition Key Differences
Public Health Service Act A federal statute aimed at improving public health. The Hematological Cancer Research Act specifically focuses on blood cancers.
Cancer Research Act A broader term that may encompass various types of cancer research. The Hematological Cancer Research Act is specifically tailored to blood cancers.

What to do if this term applies to you

If you are involved in blood cancer research or are a patient seeking information, consider reaching out to organizations that specialize in hematological cancers. You can also explore US Legal Forms for templates that can assist you in navigating related legal processes. If your situation is complex, consulting a legal professional may be beneficial.

Quick facts

Attribute Details
Year Enacted 2001
Focus Area Hematological cancers (blood cancers)
Key Agencies Involved National Institutes of Health, National Cancer Institute

Key takeaways

Frequently asked questions

The purpose is to fund and promote research and education related to blood cancers.